Sorry, you need to enable JavaScript to visit this website.

TALZENNA™ (talazoparib) Indications and Usage

1 INDICATIONS AND USAGE

TALZENNA is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA)-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. Select patients for therapy based on an FDA-approved companion diagnostic for TALZENNA [see Dosage and Administration (2.1)].

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No